LAS VEGAS – Impact investor and CNS Equity Partners CEO Jennifer Sanders was honored amongst the top 100 most influential people in the cannabis industry at the second annual High Times 100 awards. The March 27th invite-only gala at Exchange LA joined recognized leading individuals who stand out for their development and innovation in the legal cannabis space. In good company, Jennifer joined former President of Mexico, Vicente Fox, Actor Jim Belushi, TV-Talk Show Personality Montel Williams, and others also inducted as High Times honorees.
“This industry is rewarding and challenging at the same time. I have never seen such amazing acceleration in a market globally and am honored to be recognized in this industry for our work thus far. We look forward to continuing to collaborate and lead this industry in creating positive societal impact in a responsible and meaningful way.” -Jennifer Sanders
Jennifer is a Las Vegas native and Harvard University Business School graduate. Specializing in international investment, regulatory compliance, and enterprise risk management, her professional certifications include Certified Compliance and Ethics Professional, NRS Investment Advisor Certified Compliance Professional and a combination of investment securities licenses. She has worked in foreign licensure and with authorities in Canada, China, Columbia, and other countries; and also as a consultant in the international investment and banking industry.
Jennifer entered the cannabis industry in 2015 and has overseen retail, processing, and cultivation operations. She founded the nation’s first holistic health and cannabis herbal retailer, The Green Heart, which is now actively franchising across the United States, and Flora Apothecary, a luxury product line of vegan bath products and skin care. Other current projects include AURA Ventures, an innovative strategy, and creation firm that provides expert-driven solutions for industry-leading brands, companies, and products. Inspired to make positive global impact, Jennifer made the largest donation to medical research in North America (2018) to the UCLA Cannabis Research Initiative through AURA Ventures.
